Marinus Pharmaceuticals Investor Relations Material
Latest events
Investor & Analyst 2024
Marinus Pharmaceuticals
Investor Presentation
12 Nov, 2024
Q3 2024
12 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Marinus Pharmaceuticals Inc
Access all reports
Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat epilepsy with a focus on rare and orphan seizures, as well as neuropsychiatric disorders in the United States.
Key slides for Marinus Pharmaceuticals Inc
Investor & Analyst 2024
Marinus Pharmaceuticals Inc
Investor & Analyst 2024
Marinus Pharmaceuticals Inc
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
MRNS
Country
🇺🇸 United States